Chris Mackintosh

CEO, Turning Point Centers

Having Vista’s outcomes research truly differentiated Turning Point with payers.  Without it, I doubt we would have won a highly-competitive contract worth over $20 million in revenues to date.

Stay informed about the latest treatment-related research findings
Receive Treatment Insights every other Thursday in your inbox

Get your free subscription